Shahin Sanjar

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 5

Top Topics

Density Functional Theory

Top Venues

International journal of chronic obstructive pulmonary disease

Sunovion Pharmaceuticals Inc

University of London (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Sunovion Pharmaceuticals Inc Nov 11 2014

United States

Senior Director :: Global Medical Affairs

Education History

University of London Oct 01 1984

United Kingdom

PHD :: Pharmacology

Publications

Donald P Tashkin, Ayca Ozol-Godfrey, Sanjay Sharma, Shahin Sanjar
Effect of SGRQ-Defined Chronic Bronchitis at Baseline on Treatment Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate. International journal of chronic obstructive pulmonary disease 16 (2021)
Nicola A Hanania, Abebaw Mengistu Yohannes, Ayca Ozol-Godfrey, Michael Tocco, Thomas Goodin, Sanjay Sharma, Shahin Sanjar
Improvement in Lung Function and Patient-Reported Outcomes in Patients with COPD with Comorbid Anxiety and Depression Receiving Nebulized Glycopyrrolate in the GOLDEN 3 and 4 Studies. International journal of chronic obstructive pulmonary disease 16 (2021)
Nirupama Putcha, Ayca Ozol-Godfrey, Shahin Sanjar, Sanjay Sharma
Impact of Comorbidity Prevalence and Cardiovascular Disease Status on the Efficacy and Safety of Nebulized Glycopyrrolate in Patients with COPD. International journal of chronic obstructive pulmonary disease 16 (2021)
Jill A Ohar, Ayca Ozol-Godfrey, Thomas Goodin, Shahin Sanjar
Effect of Gender on Lung Function and Patient-Reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate. International journal of chronic obstructive pulmonary disease 15 (2020)
James F Donohue, Ayca Ozol-Godfrey, Thomas Goodin, Shahin Sanjar
The Effect of Baseline Rescue Medication Use on Efficacy and Safety of Nebulized Glycopyrrolate Treatment in Patients with COPD from the GOLDEN 3 and 4 Studies. International journal of chronic obstructive pulmonary disease 15 (2020)